Effect of Guided Imagery on Sleep Quality, State Anxiety, and Comfort in Patients With Acute Coronary Syndrome
The Effect of Guided Imagery on Sleep Quality, State Anxiety, and Comfort Levels in Patients With Acute Coronary Syndrome Monitored in a Cardiac Intensive Care Unit
1 other identifier
interventional
64
0 countries
N/A
Brief Summary
The goal of this randomized controlled trial is to determine whether guided imagery, when added to routine care, can reduce state anxiety and improve sleep quality and comfort in adults with acute coronary syndrome who are being treated in a cardiac intensive care unit. The main questions this study aims to answer are: Does guided imagery reduce state anxiety compared with routine care alone? Does guided imagery improve sleep quality compared with routine care alone? Does guided imagery improve comfort compared with routine care alone? A total of 64 participants will be randomly assigned to either a guided imagery group or a routine care group using block randomization. Participants in the guided imagery group will receive routine care and listen to a standardized guided imagery audio recording through headphones twice a day for two consecutive days. Each guided imagery session will last approximately 15 minutes. Participants in the routine care group will receive the standard treatment and nursing care provided in the cardiac intensive care unit without guided imagery. Researchers will assess participants' anxiety, sleep quality, and comfort and compare the changes between the two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2026
CompletedFirst Posted
Study publicly available on registry
August 31, 2026
CompletedStudy Start
First participant enrolled
November 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
Study Completion
Last participant's last visit for all outcomes
June 30, 2027
August 31, 2026
August 1, 2026
8 months
August 14, 2026
August 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in State Anxiety as Measured by the State-Trait Anxiety Inventory-State Subscale (STAI-S)
State anxiety will be assessed using the State-Trait Anxiety Inventory-State Subscale (STAI-S), a 20-item self-report measure of anxiety experienced at the present moment. The total score ranges from 20 to 80, with higher scores indicating greater state anxiety. STAI-S will be administered at baseline before the first intervention and again on the morning of Day 3 after completion of the two-day intervention period. The two measurements will be used to evaluate the effect of guided imagery compared with routine care on state anxiety over the two-day intervention period.
Baseline (Day 1, before the first intervention) and Day 3 morning after completion of the two-day intervention period
Secondary Outcomes (3)
Sleep Quality as Measured by the Richards-Campbell Sleep Questionnaire (RCSQ)
Day 2 morning and Day 3 morning
Change in Comfort as Measured by the General Comfort Questionnaire-Short Form (GCQ-SF)
Baseline (Day 1, before the first intervention) and Day 3 morning after completion of the two-day intervention period
Immediate Anxiety as Measured by the Numerical Rating Scale for Anxiety (NRS-A)
Immediately before and within 5 minutes after each daytime and evening session on Days 1 and 2
Study Arms (2)
Guided Imagery
EXPERIMENTALParticipants assigned to this arm will receive routine medical treatment and nursing care provided in the cardiac intensive care unit, in addition to guided imagery. The guided imagery intervention will be delivered using a standardized audio recording through headphones twice daily for two consecutive days. Each session will last approximately 15 minutes, with one session scheduled during the daytime and one during the evening. The recording will include relaxation preparation, attention to natural breathing, and visualization of a safe and peaceful environment.
Routine Care
NO INTERVENTIONParticipants assigned to this arm will receive routine medical treatment and nursing care provided in the cardiac intensive care unit according to their clinical needs. Routine care may include medical treatment, hemodynamic monitoring, medication administration, pain management, oxygen therapy, basic nursing care, patient education, and standard sleep-supportive care. Participants in this arm will not receive the guided imagery intervention during the study period.
Interventions
Participants assigned to the intervention group will receive guided imagery in addition to routine care. A standardized guided imagery audio recording will be delivered through headphones twice daily for two consecutive days, with one daytime and one evening session. Each session will last approximately 15 minutes. The recording includes relaxation preparation, attention to natural breathing, visualization of a safe and peaceful environment, and calming visual, auditory, and sensory imagery accompanied by low-level nature sounds. Participants will remain in a comfortable and clinically appropriate position and may stop the session at any time if they experience discomfort.
Eligibility Criteria
You may qualify if:
- Age 18 years or older.
- Diagnosed with acute coronary syndrome, specifically ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI).
- Admitted to and monitored in the cardiac intensive care unit.
- Expected to remain in the cardiac intensive care unit for at least two nights and to be transferred to a ward or discharged after the two-day study period.
- Clinically and hemodynamically stable, with no ongoing or increasing chest pain, significant respiratory distress, unstable vital signs, symptomatic serious arrhythmia, or need for urgent invasive intervention.
- Conscious, oriented to person, place, and time, and able to communicate verbally.
- Able to understand and speak Turkish.
- No hearing impairment that would prevent listening to the guided imagery audio recording through headphones.
- Sufficient cognitive ability to understand and respond to the study questionnaires.
- Willing to participate and able to provide written informed consent.
You may not qualify if:
- Diagnosis of unstable angina pectoris.
- Confusion, delirium, or any alteration in consciousness that interferes with communication.
- Diagnosed dementia or cognitive impairment that prevents understanding study instructions.
- Hearing loss that prevents following the audio instructions through headphones.
- Inability to communicate verbally.
- Clinical or hemodynamic instability, including ongoing chest pain, significant dyspnea, hemodynamic instability, symptomatic serious arrhythmia, or need for urgent intervention.
- Receiving invasive mechanical ventilation or respiratory support that interferes with communication.
- Receiving sedative treatment at a level that interferes with consciousness or communication.
- Active psychosis, severe agitation, or an active psychiatric disorder that prevents following the guided imagery instructions.
- Expected cardiac intensive care unit stay of less than two nights.
- Refusal to participate or inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 14, 2026
First Posted
August 31, 2026
Study Start (Estimated)
November 15, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
August 31, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
No formal plan has been established to share individual participant data (IPD) with other researchers. Individual participant data will not be made publicly available. Study findings will be reported in aggregate form to protect participant privacy and confidentiality.